External Content

The following content is sourced from external partners. We cannot guarantee that it is suitable for the visually or hearing impaired.

(Bloomberg) -- Royal DSM NV, the world’s largest vitamin producer, fell the most in almost a year as a surging franc threatens to increase costs and dent profit from nutrition and resin operations in Switzerland.

DSM shares fell as much as 9.3 percent to 42.75 euros in Amsterdam, valuing the Heerlen, Netherlands-based company at 7.8 billion euros ($9.1 billion). That’s the biggest intraday drop for a year and the lowest price since November 2012.

The Swiss National Bank scrapped its minimum exchange rate today, sending the franc to a record against the euro. DSM has five nutritional-ingredient facilities, two research centers and a composite plant in Switzerland, and ING analyst Filip de Pauw sees DSM facing higher costs there.

“A change of one euro cent has an impact of 5 million to 6 million euros on Ebitda,” De Pauw said. The euro lost over 17 cents in comparison to the franc, implying a currency impact of 85 million to 102 million euros, the analyst said. DSM reported earnings before interest, taxes, depreciation and amortisation from continuing operations of about 1.3 billion euros in 2013.

Shares of DSM fell 7.4 percent at 43.65 euros at 1:42 p.m. in Amsterdam.

To contact the reporter on this story: Elco van Groningen in Amsterdam at vangroningen@bloomberg.net To contact the editors responsible for this story: Simon Thiel at sthiel1@bloomberg.net Andrew Noel, Kim McLaughlin

Bloomberg